Alienor C. Berges
Oncology R&D
Cambridge, ENG, United Kingdom
Cambridge, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
Straight to Phase III: Model-Informed Approach Speeds Depemokimab Clinical Development in Interleukin-5-Driven Diseases.
Journal: Clinical pharmacology and therapeutics
Published: July 04, 2025
A Combined Model-Based Meta-Analysis of Aggregated and Individual FEV1 Data From Randomized COPD Trials.
Journal: CPT: pharmacometrics & systems pharmacology
Published: October 23, 2024
Predicting the Long-Term Effects of Therapeutic Neutralization of Oncostatin M on Human Hematopoiesis.
Journal: Clinical pharmacology and therapeutics
Published: December 13, 2023
Concentration-QT modelling in early clinical oncology settings: Simulation evaluation of performance.
Journal: British journal of clinical pharmacology
Published: April 08, 2021
Ceralasertib (AZD6738), an Oral ATR Kinase Inhibitor, in Combination with Carboplatin in Patients with Advanced Solid Tumors: A Phase I Study.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: April 06, 2021
Phase I Study of Ceralasertib (AZD6738), a Novel DNA Damage Repair Agent, in Combination with Weekly Paclitaxel in Refractory Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: January 20, 2021
QT Prolongation Risk Assessment in Oncology: Lessons Learned From Small-Molecule New Drug Applications Approved During 2011-2019.
Journal: Journal of clinical pharmacology
Published: November 08, 2020
Item Response Model Adaptation for Analyzing Data from Different Versions of Parkinson's Disease Rating Scales.
Journal: Pharmaceutical research
Published: December 21, 2018
Computer-assembled cross-species/cross-modalities two-pore physiologically based pharmacokinetic model for biologics in mice and rats.
Journal: Journal of pharmacokinetics and pharmacodynamics
Published: December 19, 2018
Bridging Olaparib Capsule and Tablet Formulations Using Population Pharmacokinetic Meta-analysis in Oncology Patients.
Journal: Clinical pharmacokinetics
Published: October 26, 2018
Efficacy and Safety Exposure-Response Analyses of Olaparib Capsule and Tablet Formulations in Oncology Patients.
Journal: Clinical pharmacology and therapeutics
Published: September 14, 2018
Time-to-Event Modeling of Left- or Right-Censored Toxicity Data in Nonclinical Drug Toxicology.
Journal: Toxicological sciences : an official journal of the Society of Toxicology
Published: May 23, 2018
Last Updated: 09/26/2026